A simple approach for restoration of differentiation and function in cryopreserved human hepatocytes.


Journal

Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615

Informations de publication

Date de publication:
03 2019
Historique:
received: 14 11 2018
accepted: 10 12 2018
pubmed: 19 12 2018
medline: 19 5 2020
entrez: 19 12 2018
Statut: ppublish

Résumé

Primary human hepatocytes are used in all facets of liver research, from in vitro studies of xenobiotic disposition and toxicity to the clinical management of liver failure. Unfortunately, cellular stress during isolation and cryopreservation causes a highly unpredictable loss of the ability to attach and form cell-matrix and cell-cell interactions. Reasoning that this problem could be mitigated at the post-thawing stage, we applied label-free quantitative global proteomics to analyze differences between attached and non-attached fractions of cryopreserved human hepatocyte batches. Hepatocytes that were unable to attach to a collagen matrix showed many signs of cellular stress, including a glycolytic phenotype and activation of the heat shock response, ultimately leading to apoptosis activation. Further analysis of the activated stress pathways revealed an increase in early apoptosis immediately post-thawing, which suggested the possibility of stress reversal. Therefore, we transiently treated the cells with compounds aimed at decreasing cellular stress via different mechanisms. Brief exposure to the pan-caspase apoptosis inhibitor Z-VAD-FMK restored attachment ability and promoted a differentiated morphology, as well as formation of 3D spheroids. Further, Z-VAD-FMK treatment restored metabolic and transport functions, with maintained sensitivity to hepatotoxic insults. Altogether, this study shows that differentiation and function of suboptimal human hepatocytes can be restored after cryopreservation, thus markedly increasing the availability of these precious cells.

Identifiants

pubmed: 30560367
doi: 10.1007/s00204-018-2375-9
pii: 10.1007/s00204-018-2375-9
doi:

Substances chimiques

Amino Acid Chloromethyl Ketones 0
Caspase Inhibitors 0
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone 0
Caspases EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

819-829

Subventions

Organisme : Vetenskapsrådet
ID : 2822
Pays : International
Organisme : Vetenskapsrådet
ID : 01951
Pays : International

Auteurs

Magnus Ölander (M)

Department of Pharmacy, Uppsala University, 75123, Uppsala, Sweden.

Jacek R Wiśniewski (JR)

Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.

Inken Flörkemeier (I)

Department of Pharmacy, Uppsala University, 75123, Uppsala, Sweden.

Niklas Handin (N)

Department of Pharmacy, Uppsala University, 75123, Uppsala, Sweden.

Jozef Urdzik (J)

Department of Surgical Sciences, Uppsala University, 75185, Uppsala, Sweden.

Per Artursson (P)

Department of Pharmacy and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. per.artursson@farmaci.uu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH